Literature DB >> 17234589

Activation of PAR-1 kinase and stimulation of tau phosphorylation by diverse signals require the tumor suppressor protein LKB1.

Ji-Wu Wang1, Yuzuru Imai, Bingwei Lu.   

Abstract

Aberrant phosphorylation of tau is associated with a number of neurodegenerative diseases, including Alzheimer's disease (AD). The molecular mechanisms by which tau phosphorylation is regulated under normal and disease conditions are not well understood. Microtubule affinity regulating kinase (MARK) and PAR-1 have been identified as physiological tau kinases, and aberrant phosphorylation of MARK/PAR-1 target sites in tau has been observed in AD patients and animal models. Here we show that phosphorylation of PAR-1 by the tumor suppressor protein LKB1 is required for PAR-1 activation, which in turn promotes tau phosphorylation in Drosophila. Diverse stress stimuli, such as high osmolarity and overexpression of the human beta-amyloid precursor protein, can promote PAR-1 activation and tau phosphorylation in an LKB1-dependent manner. These results reveal a new function for the tumor suppressor protein LKB1 in a signaling cascade through which the phosphorylation and function of tau is regulated by diverse signals under physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234589      PMCID: PMC6672797          DOI: 10.1523/JNEUROSCI.5094-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

Review 1.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.

Authors:  J Lewis; E McGowan; J Rockwood; H Melrose; P Nacharaju; M Van Slegtenhorst; K Gwinn-Hardy; M Paul Murphy; M Baker; X Yu; K Duff; J Hardy; A Corral; W L Lin; S H Yen; D W Dickson; P Davies; M Hutton
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

3.  Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

Authors:  T Ishihara; M Hong; B Zhang; Y Nakagawa; M K Lee; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

4.  PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.

Authors:  T Q Sun; B Lu; J J Feng; C Reinhard; Y N Jan; W J Fantl; L T Williams
Journal:  Nat Cell Biol       Date:  2001-07       Impact factor: 28.824

5.  Modulation of tau phosphorylation and intracellular localization by cellular stress.

Authors:  S M Jenkins; M Zinnerman; C Garner; G V Johnson
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

6.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.

Authors:  A Probst; J Götz; K H Wiederhold; M Tolnay; C Mistl; A L Jaton; M Hong; T Ishihara; V M Lee; J Q Trojanowski; R Jakes; R A Crowther; M G Spillantini; K Bürki; M Goedert
Journal:  Acta Neuropathol       Date:  2000-05       Impact factor: 17.088

7.  Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.

Authors:  C W Wittmann; M F Wszolek; J M Shulman; P M Salvaterra; J Lewis; M Hutton; M B Feany
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

8.  Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.

Authors:  J J Lucas; F Hernández; P Gómez-Ramos; M A Morán; R Hen; J Avila
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

9.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

10.  Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study.

Authors:  J Y Chin; R B Knowles; A Schneider; G Drewes; E M Mandelkow; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

View more
  50 in total

1.  Targeting therapeutic effects: subcellular location matters. Focus on "Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology".

Authors:  Judy Creighton
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-28       Impact factor: 4.249

Review 2.  Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Authors:  Narendran Annadurai; Khushboo Agrawal; Petr Džubák; Marián Hajdúch; Viswanath Das
Journal:  Cell Mol Life Sci       Date:  2017-06-20       Impact factor: 9.261

Review 3.  Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseases.

Authors:  Stephen Amato; Heng-Ye Man
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

4.  Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation.

Authors:  Nicola J Bright; David Carling; Claire Thornton
Journal:  J Biol Chem       Date:  2008-03-13       Impact factor: 5.157

Review 5.  Recent advances in using Drosophila to model neurodegenerative diseases.

Authors:  Bingwei Lu
Journal:  Apoptosis       Date:  2009-08       Impact factor: 4.677

6.  Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated Aβ toxicity in Drosophila.

Authors:  Seongsoo Lee; Ji-Wu Wang; Wendou Yu; Bingwei Lu
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

7.  Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease.

Authors:  Lixia Qin; Qian Xu; Ziyi Li; Li Chen; Yujing Li; Nannan Yang; Zhenhua Liu; Jifeng Guo; Lu Shen; Emily G Allen; Chao Chen; Chao Ma; Hao Wu; Xiongwei Zhu; Peng Jin; Beisha Tang
Journal:  Hum Mol Genet       Date:  2020-01-01       Impact factor: 6.150

8.  Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.

Authors:  Kanae Ando; Mikiko Oka; Yosuke Ohtake; Motoki Hayashishita; Sawako Shimizu; Shin-Ichi Hisanaga; Koichi M Iijima
Journal:  Biochem Biophys Res Commun       Date:  2016-08-09       Impact factor: 3.575

Review 9.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

10.  Differential control of Yorkie activity by LKB1/AMPK and the Hippo/Warts cascade in the central nervous system.

Authors:  Ieva Gailite; Birgit L Aerne; Nicolas Tapon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.